Chemical Structure : TPST-1495
Catalog No.: PC-21037Not For Human Use, Lab Use Only.
TPST-1495 (TPST1495) is a potent, selective, orally available dual EP2/EP4 PGE2 receptor antagonist with IC50 of 17.21/3.24 nM, respectively.
Packing | Price | Stock | Quantity |
---|
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
TPST-1495 (TPST1495) is a potent, selective, orally available dual EP2/EP4 PGE2 receptor antagonist with IC50 of 17.21/3.24 nM, respectively.
TPST-1495 does not achieve 50% inhibition of EP1 or EP3 receptors at concentrations up to 30 uM.
TPST-1495 rescues production of TNFα by monocytes at both low and high PGE2 concentrations with IC50 values of 1 nmol/L and 382 nmol/L, respectively, overcomes PGE2-mediated immune suppression in mouse and human monocytes in vitro.
TPST-1495 is more effective than a single EP4 or EP2 antagonists (E7046 and PF04419848) in overcoming PGE2-mediated immune suppression of recovery of cytokine production from murine monocytes and T cells.
TPST-1495 (100 mg/kg twice a day, orally) confers therapeutic efficacy in mice bearing PGE2-producing tumors.
TPST-1495 exhibits immune-independent antitumor activity.
M.Wt | ||
Formula | ||
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright